GPi688
GPi688 is a potent and orally active glycogen phosphorylase (GPa) inhibitor with IC50s of 19 nM, 61 nM and 12 nM for human liver GPa, rat liver GPa and human skeletal muscle GPa, respectively[1]. GPi688 can inhibit glucagons-mediated glucose output in rat primary hepatocytes. GPi688 can be used for researching glucagon-mediated hyperglycaemia[2].
Product Specifications
CAS Number
918902-32-6
UNSPSC
12352005
Target
Phosphorylase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/gpi688.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=CC(C=C(Cl)S2)=C2N1)NC3C(N(C[C@@H](O)CO)C4=C(C=CC=C4)C3)=O
Molecular Formula
C19H18ClN3O4S
Molecular Weight
419.88
References & Citations
[1]Freeman S, et al. Sensitivity of glycogen phosphorylase isoforms to indole site inhibitors is markedly dependent on the activation state of the enzyme. Br J Pharmacol. 2006;149 (6) :775-785.|[2]Poucher SM, et al. An assessment of the in vivo efficacy of the glycogen phosphorylase inhibitor GPi688 in rat models of hyperglycaemia. Br J Pharmacol. 2007;152 (8) :1239-1247.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
NBP2-47662MFV500 0.1 mL
Mouse Monoclonal Actin (Muscle Specific) Antibody (MSA/953) [mFluor Violet 500 SE]
Sign In for Pricing
View Details MBS1488137 Inquire
Recombinant Staphylococcus haemolyticus UvrABC system protein C (uvrC), partial
Sign In for Pricing
View Details 
VAng-Yyj3863-500gEcoli 500 µg (E. coli)
Recombinant Mycobacterium Ulcerans tuf Protein (aa 1-396)
Sign In for Pricing
View Details 
